Manufacturers Life Insurance Company, The Arbutus Biopharma Corp Transaction History
Manufacturers Life Insurance Company, The
- $102 Billion
- Q2 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 57,323 shares of ABUS stock, worth $225,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,323
Previous 53,132
7.89%
Holding current value
$225,852
Previous $137,000
29.2%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ABUS
# of Institutions
138Shares Held
95.4MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$82.6 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$50.7 Million30.08% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$45.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$33.8 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$27.7 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $591M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...